Anterix CFO sells shares, exercises options
Anterix Inc.’s Chief Financial Officer Elena Marquez reported an open‑market sale and an option exercise involving the company’s common stock.
Rhea-AI Filing Summary
Anterix Inc.’s Chief Financial Officer Elena Marquez reported an open‑market sale and an option exercise involving the company’s common stock. On June 17, 2026, she sold 4,291 shares at $79.50 per share and exercised stock options for 1,226 shares at $40.00 per share. Following these transactions, she directly holds 18,387 shares of common stock and 2,454 stock options. The option grant referenced in the filing vests in three equal annual installments beginning on October 4, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Marquez Elena
Role
Chief Financial Officer
Sold
4,291 shs ($341K)
Approx. gross sale proceeds
$341K
Approx. exercise cost
$49K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,226 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,226 | $40.00 | $49K |
| Sale | Common Stock | 4,291 | $79.50 | $341K |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,454 contracts (Direct);
Common Stock — 18,387 shares (Direct)
Footnotes (1)
- F1. The option shares vest and become exercisable in three equal annual installments beginning on October 4, 2025.
Key Figures
Shares sold: 4,291 shares
Sale price: $79.50 per share
Options exercised: 1,226 shares
+5 more
8 metrics
Shares sold
4,291 shares
Open-market sale of common stock on June 17, 2026
Sale price
$79.50 per share
Price for 4,291 common shares sold
Options exercised
1,226 shares
Common shares acquired via option exercise on June 17, 2026
Option exercise price
$40.00 per share
Exercise or conversion price for stock options
Common shares held
18,387 shares
Direct common stock ownership after reported sale
Options remaining
2,454 options
Stock Option (Right to Buy) balance after exercise
Option vesting start
October 4, 2025
Option shares vest in three equal annual installments beginning on this date
Option expiration
April 3, 2035
Expiration date of the Stock Option (Right to Buy)
Key Terms
open-market sale, Stock Option (Right to Buy), derivative security, Chief Financial Officer, +1 more
5 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
""security_title": "Stock Option (Right to Buy)""
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Chief Financial Officer financial
""officer_title": "Chief Financial Officer""
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
vest and become exercisable financial
"The option shares vest and become exercisable in three equal annual installments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Anterix (ATEX) CFO Elena Marquez report?
Anterix CFO Elena Marquez reported selling 4,291 common shares and exercising options for 1,226 shares. Both transactions occurred on June 17, 2026, and involved open‑market activity and derivative exercise disclosed in a Form 4 insider trading report.
What stock options did the Anterix (ATEX) CFO exercise in this Form 4?
The CFO exercised stock options to acquire 1,226 Anterix common shares at an exercise price of $40.00 per share. A related derivative entry shows these options as “Stock Option (Right to Buy)” tied to the underlying common stock.
What are Elena Marquez’s Anterix (ATEX) holdings after these transactions?
After the reported transactions, Elena Marquez directly holds 18,387 shares of Anterix common stock. The filing also shows 2,454 stock options remaining, providing additional potential future ownership beyond her current common share position.
How do the Anterix (ATEX) CFO’s stock options vest and when do they expire?
According to the footnote, the option shares vest in three equal annual installments beginning on October 4, 2025. The derivative transaction table lists an expiration date for the stock option grant of April 3, 2035, defining its long‑term exercisability window.
Was the Anterix (ATEX) CFO’s sale classified as an open‑market transaction?
Yes. The Form 4 classifies the 4,291‑share disposition as an open‑market sale of common stock. The transaction code “S” and description “Sale in open market or private transaction” identify it as a straightforward, non‑derivative stock sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
